Article
Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer's Disease.
Cells - 29 Jun 2021
Vlachakis Dimitrios, Papakonstantinou Eleni, Sagar Ram, Bacopoulou Flora, Exarchos Themis, Kourouthanassis Panos, Karyotis Vasileios, Vlamos Panayiotis, Lyketsos Constantine, Avramopoulos Dimitrios, Mahairaki Vasiliki
Abstract excerpt
The treatment of complex and multifactorial diseases constitutes a big challenge in day-to-day clinical practice. As many parameters influence clinical phenotypes, accurate diagnosis and prompt therapeutic management is often difficult. Significant research and investment focuses on state-of-the-art genomic and metagenomic analyses in the burgeoning field of Precision (or Personalized) Medicine with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
